PF-00885706
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-00885706, covering 2011-07-14 to 2011-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) [Phase 2]